Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Condition:   COPD Interventions:   Drug: RPL554 suspension;   Drug: Placebo Sponsor:   Verona Pharma plc Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials